oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes news today 2025 soul trial results High- Risk Diabetes: Benefit Confirmed in the SOUL Trial Shows Oral Semaglutide – Semaglutide 2.4 mg delivered a – VisualAbstract: Semaglutide Improves Outcomes in
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


























